莫西沙星治疗糖尿病合并下呼吸道感染的疗效分析

Analysis of Curative Effect of Moxifloxacin in Treatment of Diabetes Combined with Lower Respiratory Tract Infection

目的探讨莫西沙星治疗糖尿病合并下呼吸道感染的疗效。方法收集该院2016年12月—2017年12月收治的糖尿病合并下呼吸道感染患者94例,随机分为两组各47例,观察组给予莫西沙星,对照组给予左氧氟沙星,比较疗效。结果观察组总有效率为93.6%,明显优于对照组78.7%(P<0.05);观察组FBG(6.3±0.5)mmol/L、2 h PBG(7.8±0.6)mmol/L,显著低于对照组(P<0.05);两组不良反应比较差异无统计学意义(P>0.05)。结论对糖尿病合并下呼吸道感染患者采用莫西沙星治疗,可有效提高治疗效果,控制血糖,值得应用。

Objective To study the curative effect of moxifloxacin in treatment of diabetes combined with lower respiratory tract infection. Methods 94 cases of patients with diabetes combined with lower respiratory tract infection admitted and treated in our hospital from December 2016 to December 2017 were collected and randomly divided into two groups with 47 cases in each, the observation group and the control group were respectively treated with moxifloxacin and levofloxacin, and the curative effect was compared between the two groups. Results The total effective rate in the observation group was obviously better than that in the control group（93.6% vs 78.7%）（P〈0.05）, and the FBG（6.3±0.5）mmol/L,2 h PBG（7.8±0.6）mmol/L in the observation group were obviously lower than those in the control group（P〈0.05）, and the differences in the adverse reactions between the two groups were not statistically significant（P〉0.05）. Conclusion The moxifloxacin in treatment of diabetes combined with lower respiratory tract infection can effectively improve the treatment effect and control the blood glucose, and it is worth application.